Next Article in Journal
ASA Suppresses PGE2 in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma
Previous Article in Journal
Special Issue “Carbohydrates 2018”
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

2019: An Awesome Year for Pharmaceuticals

Jean Jacques Vanden Eynde
Editor-in-Chief, MDPI AG, St. Alban-Anlage 66, 4052 Basel, Switzerland
Pharmaceuticals 2020, 13(1), 6;
Submission received: 30 December 2019 / Accepted: 30 December 2019 / Published: 1 January 2020
Ending the year is an opportunity to reflect on the past, in particular the past twelve months. Without any exaggeration, we may say that our Journal Pharmaceuticals is growing [1] in a wonderful and successful way. Since 2015 the number of papers published annually jumped from 45 to 186 in 2019. That impressive number constitutes a tied record with Volume 3 edited in 2010. As a result, starting in 2020, Pharmaceuticals will be published on a monthly basis. Another milestone has been achieved by releasing the 1000th article in September, a contribution of B. O’Brien, S.J. Mathew, et al. [2]. Mention must also be made to the 17 Special Issues of this past year, three of them are the subject of printed books. The development of our Journal is, indubitably, the result of the dynamic and enthusiastic work of the editorial staff and all the editorial board members. Let me also underline that in 2019 five eminent female scientists, namely Martina Benesova (Heidelberg, Germany), Micheline Draye (Le Bourget du Lac, France), María Jesús Pérez Pérez (Madrid, Spain), Amelia Pilar Rauter (Lisboa, Portugal), and Svetiana Tsogoeva (Erlangen, Germany), joined the board [3].
In order to establish its worldwide reputation, our Journal acted in a media partnership and as a sponsor for numerous colloquia in different countries. Among them, we had the opportunity to promote Pharmaceuticals during the 257th national meeting and exhibition of the American Chemical Society in Orlando (FL, USA) in April. In August, we had the pleasure to announce that the 2019 Pharmaceuticals Travel Award [4] was granted to Jorge Henrique Ferreira Grilo, a Ph.D. student. Several other travel grants were also offered to reward young researchers and renowned scientists for their outstanding works. Such was the case during the 5th International Electronic Conference on Medicinal Chemistry [5], an event organized and sponsored by our Journal. That edition marked another noticeable milestone for Pharmaceuticals; indeed, it gathered a record of more than 400 authors and thousands of visitors. The 116 accepted abstracts were divided into three sessions: posters, presentations (soundless), and keynote presentations (videos with sound). It is noteworthy to address that conference speakers were evenly distributed between women and men. For each session, the scientific committee had the hard task of selecting the best work. Finally, travel grants were awarded to Elena González-Burgos, et al. for best poster [6]; Thines Kanagasundaram, et al. for best presentation [7]; and Edeildo Ferreira da Silva-Júnior, et al. for best keynote presentation [8]. The 6th edition of the series will be held on the web in November 2020. We are awaiting your submissions!
Do you remember my editorial [9] published in July 2017? In that note, I expressed my amazement because Pharmaceuticals had an excellent CiteScore™ (4.90 for 2016), as calculated by Elsevier, but was still awaiting its first journal impact factor, as estimated by Clarivate Analytics. Exceptional news was received in November—Pharmaceuticals has been accepted by World of Science™ (WoS™; Clarivate Analytics) to be included in the Science Citation Index Expanded (SCIE). This means that the first impact factor of our Journal will be announced in June 2020.
To close this editorial, I would like to thank all our authors, reviewers, readers, and members of the editorial board and editorial offices for their confidence and continuous support. Pharmaceuticals could not be what it has become without your efforts and dynamism. May 2020 bring you 366 days of health, joy, and happiness.


This research received no external funding.

Conflicts of Interest

The author declares no conflict of interest.


  1. Vanden Eynde, J.J. Progress Confirmed for Pharmaceuticals in 2016. Pharmaceuticals 2017, 10, 1. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. O’Brien, B.; Lijffijt, M.; Wells, A.L.; Swann, A.C.; Mathew, S.J. The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression. Pharmaceuticals 2019, 12, 133. [Google Scholar] [CrossRef] [Green Version]
  3. The Editorial Board of Pharmaceuticals. Available online: (accessed on 31 December 2019).
  4. The 2019 Pharmaceuticals Travel Award Winner. Available online: (accessed on 31 December 2019).
  5. The 5th International Electronic Conference on Medicinal Chemistry. Available online: (accessed on 31 December 2019).
  6. Fraga Matías, N.; Ureña Vacas, I.M.; González-Burgos, E.; Gómez-Serranillos, M.P. Biological evaluation of Cetrarioid clade as cholinesterase inhibitors. In Proceedings of the 5th International Electronic Conference on Medicinal Chemistry, 1–30 November 2019. Session Posters. [Google Scholar] [CrossRef] [Green Version]
  7. Kanagasundaram, T.; Kramer, C.S.; Boros, E.; Kopka, K. Novel radiolabeled silicon rhodamine dyes for bimodal scintigraphic and optical imaging. In Proceedings of the 5th International Electronic Conference on Medicinal Chemistry, 1–30 November 2019. [Google Scholar] [CrossRef] [Green Version]
  8. Ferreira da Silva-Júnior, E.; Silva Passos, G.F.; Moura Gomes, M.G.; Mendonça de Aquino, T.; Maia de Souza, S.J.; Monteiro Cavalcante, J.P.; Conceição dos Santos, E.; Bassi, E.J.; Xavier de Araújo-Júnior, J. Design, synthesis and in vitro biological evaluation of acrylamide derivatives against Chikungunya virus. In Proceedings of the 5th International Electronic Conference on Medicinal Chemistry, 1–30 November 2019. Session Keynote Presentation. [Google Scholar] [CrossRef] [Green Version]
  9. Vanden Eynde, J.J. Pharmaceuticals: Impact Factor or CiteScore™. Pharmaceuticals 2017, 10, 61. [Google Scholar] [CrossRef] [Green Version]

Share and Cite

MDPI and ACS Style

Vanden Eynde, J.J. 2019: An Awesome Year for Pharmaceuticals. Pharmaceuticals 2020, 13, 6.

AMA Style

Vanden Eynde JJ. 2019: An Awesome Year for Pharmaceuticals. Pharmaceuticals. 2020; 13(1):6.

Chicago/Turabian Style

Vanden Eynde, Jean Jacques. 2020. "2019: An Awesome Year for Pharmaceuticals" Pharmaceuticals 13, no. 1: 6.

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop